Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
About this item
Full title
Author / Creator
Ridker, Paul M , Everett, Brendan M , Pradhan, Aruna , MacFadyen, Jean G , Solomon, Daniel H , Zaharris, Elaine , Mam, Virak , Hasan, Ahmed , Rosenberg, Yves , Iturriaga, Erin , Gupta, Milan , Tsigoulis, Michelle , Verma, Subodh , Clearfield, Michael , Libby, Peter , Goldhaber, Samuel Z , Seagle, Roger , Ofori, Cyril , Saklayen, Mohammad , Butman, Samuel , Singh, Narendra , Le May, Michel , Bertrand, Olivier , Johnston, James , Paynter, Nina P , Glynn, Robert J and CIRT Investigators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Patients with coronary artery disease were randomly assigned to either methotrexate (15 to 20 mg weekly) or placebo. At a median of 2.3 years, there was no difference between the two groups in the rate of myocardial infarction, stroke, or cardiovascular death.
Alternative Titles
Full title
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Authors, Artists and Contributors
Author / Creator
Everett, Brendan M
Pradhan, Aruna
MacFadyen, Jean G
Solomon, Daniel H
Zaharris, Elaine
Mam, Virak
Hasan, Ahmed
Rosenberg, Yves
Iturriaga, Erin
Gupta, Milan
Tsigoulis, Michelle
Verma, Subodh
Clearfield, Michael
Libby, Peter
Goldhaber, Samuel Z
Seagle, Roger
Ofori, Cyril
Saklayen, Mohammad
Butman, Samuel
Singh, Narendra
Le May, Michel
Bertrand, Olivier
Johnston, James
Paynter, Nina P
Glynn, Robert J
CIRT Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6587584
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6587584
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1809798
